Comparison of Cancer Diagnoses Between the US Solid Organ Transplant Registry and Linked Central Cancer Registries
- PMID: 27062091
- PMCID: PMC5055411
- DOI: 10.1111/ajt.13818
Comparison of Cancer Diagnoses Between the US Solid Organ Transplant Registry and Linked Central Cancer Registries
Abstract
US transplant centers are required to report cancers in transplant recipients to the transplant network. The accuracy and completeness of these data, collected in the Scientific Registry of Transplant Recipients (SRTR), are unknown. We compared diagnoses in the SRTR and 15 linked cancer registries for colorectal, liver, lung, breast, prostate and kidney cancers; melanoma; and non-Hodgkin lymphoma (NHL). Among 187 384 transplants, 9323 cancers were documented in the SRTR or cancer registries. Only 36.8% of cancers were in both, with 47.5% and 15.7% of cases additionally documented solely in cancer registries or the SRTR, respectively. Agreement between the SRTR and cancer registries varied (kappa = 0.28 for liver cancer and kappa = 0.52-0.66 for lung, prostate, kidney, colorectum, and breast cancers). Upon evaluation, some NHLs documented only in cancer registries were identified in the SRTR as another type of posttransplant lymphoproliferative disorder. Some SRTR-only cases were explained by miscoding (colorectal cancer instead of anal cancer, metastases as lung or liver cancers) or missed matches with cancer registries, partly due to recipients' outmigration from catchment areas. Estimated sensitivity for identifying cancer was 52.5% for the SRTR and 84.3% for cancer registries. In conclusion, SRTR cancer data are substantially incomplete, limiting their usefulness for surveillance and research.
Keywords: Organ Procurement and Transplantation Network (OPTN); cancer/malignancy/neoplasia; clinical research/practice; health services and outcomes research; hematology/oncology.
© Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.
Figures
References
-
- Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59–67. - PubMed
-
- Mbulaiteye SM, Engels EA. Kaposi’s sarcoma risk among transplant recipients in the United States (1993–2003) Int J Cancer. 2006;119:2685–91. - PubMed
Publication types
MeSH terms
Grants and funding
- U58 DP003931/DP/NCCDPHP CDC HHS/United States
- HHSN261201000037C/CA/NCI NIH HHS/United States
- U58 DP003875/DP/NCCDPHP CDC HHS/United States
- N01 PC035139/CA/NCI NIH HHS/United States
- N01 PC035137/CA/NCI NIH HHS/United States
- HHSN261201300071C/CA/NCI NIH HHS/United States
- U58 DP003920/DP/NCCDPHP CDC HHS/United States
- N01 PC035142/CA/NCI NIH HHS/United States
- HHSN261201300011I/CA/NCI NIH HHS/United States
- U58 DP000832/DP/NCCDPHP CDC HHS/United States
- U58 DP000824/DP/NCCDPHP CDC HHS/United States
- U58 DP003883/DP/NCCDPHP CDC HHS/United States
- N01 PC035143/CA/NCI NIH HHS/United States
- HHSN261201000036C/CA/NCI NIH HHS/United States
- U58 DP003879/DP/NCCDPHP CDC HHS/United States
- HHSN261201300011C/RC/CCR NIH HHS/United States
- U58 DP000807/DP/NCCDPHP CDC HHS/United States
- HHSN261201300021C/CA/NCI NIH HHS/United States
- HHSN261201000035I/CA/NCI NIH HHS/United States
- U58 DP000848/DP/NCCDPHP CDC HHS/United States
- Z01 CP010150/ImNIH/Intramural NIH HHS/United States
- HHSN261201000024C/CA/NCI NIH HHS/United States
- HHSN261201000035C/PC/NCI NIH HHS/United States
- HHSN261201000034C/CA/NCI NIH HHS/United States
- U58 DP003921/DP/NCCDPHP CDC HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
